The Traderszone Network

Published in TZ Latest News 1 April, 2017 by The TZ Newswire Staff

J&J Wins $30B Tender Offer for Swiss Biotech Co.

The healthcare leader plans to delist Actelion and spin off a new R&D company called Idorsia.